Literature DB >> 14573544

Target-specific neuropeptide Y-ergic synaptic inhibition and its network consequences within the mammalian thalamus.

Qian-Quan Sun1, Scott C Baraban, David A Prince, John R Huguenard.   

Abstract

Neuropeptides are commonly colocalized with classical neurotransmitters, yet there is little evidence for peptidergic neurotransmission in the mammalian CNS. We performed whole-cell patch-clamp recording from rodent thalamic brain slices and repetitively stimulated corticothalamic fibers to strongly activate NPY-containing GABAergic reticular thalamic (RT) neurons. This resulted in long-lasting (approximately 10 sec) feedforward slow IPSPs (sIPSPs) in RT cells, which were mimicked and blocked by NPY1 (Y1) receptor agonists and antagonists, respectively, and were present in wild-type mice but absent in NPY-/- mice. NPYergic sIPSPs were mediated via G-proteins and G-protein-activated, inwardly rectifying potassium channels, as evidenced by sensitivity to GDP-beta-S and 0.1 mm Ba2+. In rat RT neurons, NPYergic sIPSPs were also present but were surprisingly absent in the major synaptic targets of RT, thalamic relay neurons, where instead robust GABA(B) IPSPs occurred. In vitro oscillatory network responses in rat thalamus were suppressed and augmented by Y1 agonists and antagonists, respectively. These findings provide evidence for segregation of postsynaptic actions between two targets of RT cells and support a role for endogenously released NPY within RT in the regulation of oscillatory thalamic responses relevant to sleep and epilepsy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573544      PMCID: PMC6740476     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  56 in total

Review 1.  Neuronal circuitry of thalamocortical epilepsy and mechanisms of antiabsence drug action.

Authors:  J R Huguenard
Journal:  Adv Neurol       Date:  1999

2.  Contributions of residual calcium to fast synaptic transmission.

Authors:  C Chen; W G Regehr
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

Review 3.  Facilitation, augmentation and potentiation at central synapses.

Authors:  A M Thomson
Journal:  Trends Neurosci       Date:  2000-07       Impact factor: 13.837

Review 4.  Neuropeptides--an overview.

Authors:  T Hökfelt; C Broberger; Z Q Xu; V Sergeyev; R Ubink; M Diez
Journal:  Neuropharmacology       Date:  2000-06-08       Impact factor: 5.250

Review 5.  Target-specific expression of pre- and postsynaptic mechanisms.

Authors:  K Tóth; C J McBain
Journal:  J Physiol       Date:  2000-05-15       Impact factor: 5.182

6.  Dependence of transient and residual calcium dynamics on action-potential patterning during neuropeptide secretion.

Authors:  M Muschol; B M Salzberg
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

7.  Predominance of corticothalamic synaptic inputs to thalamic reticular nucleus neurons in the rat.

Authors:  X B Liu; E G Jones
Journal:  J Comp Neurol       Date:  1999-11-08       Impact factor: 3.215

8.  Target-cell-specific facilitation and depression in neocortical circuits.

Authors:  A Reyes; R Lujan; A Rozov; N Burnashev; P Somogyi; B Sakmann
Journal:  Nat Neurosci       Date:  1998-08       Impact factor: 24.884

9.  Corticotropin-releasing factor plays a permissive role in cerebellar long-term depression.

Authors:  M Miyata; D Okada; K Hashimoto; M Kano; M Ito
Journal:  Neuron       Date:  1999-04       Impact factor: 17.173

10.  The action of thyrotropin-releasing hormone, substance P and related peptides on frog spinal motoneurons.

Authors:  R A Nicoll
Journal:  J Pharmacol Exp Ther       Date:  1978-12       Impact factor: 4.030

View more
  23 in total

1.  Frequency-dependent release of substance P mediates heterosynaptic potentiation of glutamatergic synaptic responses in the rat visual thalamus.

Authors:  Sean P Masterson; Jianli Li; Martha E Bickford
Journal:  J Neurophysiol       Date:  2010-07-21       Impact factor: 2.714

Review 2.  Neuropeptide Y in the recurrent mossy fiber pathway.

Authors:  J Victor Nadler; Bin Tu; Olga Timofeeva; Yiqun Jiao; Herbert Herzog
Journal:  Peptides       Date:  2007-01-03       Impact factor: 3.750

3.  Valproate enhances neuropeptide y expression: modulating the modulators.

Authors:  Andre H Lagrange
Journal:  Epilepsy Curr       Date:  2007 Jul-Aug       Impact factor: 7.500

4.  Neuropeptide Y directly inhibits neuronal activity in a subpopulation of gonadotropin-releasing hormone-1 neurons via Y1 receptors.

Authors:  Ulrike Klenke; Stephanie Constantin; Susan Wray
Journal:  Endocrinology       Date:  2010-03-29       Impact factor: 4.736

5.  Presynaptic inhibition selectively weakens peptidergic cotransmission in a small motor system.

Authors:  Nicholas D DeLong; Mark P Beenhakker; Michael P Nusbaum
Journal:  J Neurophysiol       Date:  2009-10-14       Impact factor: 2.714

6.  NPY signaling through Y1 receptors modulates thalamic oscillations.

Authors:  Julia Brill; Gunnar Kwakye; John R Huguenard
Journal:  Peptides       Date:  2006-12-29       Impact factor: 3.750

Review 7.  Valproic Acid: second generation.

Authors:  Meir Bialer; Boris Yagen
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

Review 8.  Functional consequences of neuropeptide and small-molecule co-transmission.

Authors:  Michael P Nusbaum; Dawn M Blitz; Eve Marder
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

9.  A neural circuit mechanism integrating motivational state with memory expression in Drosophila.

Authors:  Michael J Krashes; Shamik DasGupta; Andrew Vreede; Benjamin White; J Douglas Armstrong; Scott Waddell
Journal:  Cell       Date:  2009-10-16       Impact factor: 41.582

10.  Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system.

Authors:  Li-Ying Fu; Claudio Acuna-Goycolea; Anthony N van den Pol
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.